Immuron (IMRN) Enterprise Value Growth (1y) (2017 - 2025)
Immuron (IMRN) Enterprise Value Growth (1y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Immuron |
921.61 Mn |
921.58 Mn |
- |
| Date | Value |
|---|
| Sep 2, 2025 |
99.76% |
| Jun 30, 2025 |
76.40% |
| Dec 31, 2024 |
54.71% |
| Sep 9, 2024 |
32.07% |
| Jun 30, 2024 |
39.48% |
| Dec 31, 2023 |
32.12% |
| Aug 30, 2023 |
-11.60% |
| Jun 30, 2023 |
19.84% |
| Dec 31, 2022 |
-591.63% |
| Jun 30, 2022 |
17.89% |
| Dec 31, 2021 |
36.42% |
| Jun 30, 2021 |
-805.35% |
| Dec 31, 2020 |
-11,413.12% |
| Jun 30, 2020 |
40.60% |
| Dec 31, 2019 |
99.31% |
| Jun 30, 2019 |
-0.21% |
| Dec 31, 2018 |
-51.84% |
| Sep 27, 2018 |
-9.81% |
| Aug 30, 2018 |
-18.34% |
| Jun 30, 2018 |
-19.25% |
